Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

China Shenghuo Gains Foothold In U.S. Market With TCM Products

This article was originally published in PharmAsia News

Executive Summary

SHANGHAI - China Shenghuo Pharmaceutical will launch its new traditional Chinese medicine-based 12Ways Skin Care products in the U.S. during the first quarter of 2008, the company announced Feb. 7

You may also be interested in...



China Shenghuo Sees Sales Boost In Rural Markets From New Health Care Reform And Expanding Retail Cosmetics

SHANGHAI - China Shenghuo Pharmaceutical saw sales growth in China's rural areas thanks to new medical reforms in China during the first nine months of 2008, company President Lan Feng told a Nov. 25 earnings call

China Shenghuo Sees Sales Boost In Rural Markets From New Health Care Reform And Expanding Retail Cosmetics

SHANGHAI - China Shenghuo Pharmaceutical saw sales growth in China's rural areas thanks to new medical reforms in China during the first nine months of 2008, company President Lan Feng told a Nov. 25 earnings call

Upbeat Outlook For TCM Industry

The Chinese government issued several policies and statutes to support the development of traditional Chinese medicine, breathing fresh life into the sector. Analysts predict that both traditional Chinese medicine sales revenues and profits are expected to grow more than 20 percent in 2008 due to several factors: Per capita health care expenditure is climbing steadily; the government is increasing investment to promote the modernization and internationalization of TCM; health reforms and medical insurance for urban and rural communities could potentially expand the medical market to 100 billion yuan; and a lower standard tax rate of 25 percent for domestic and foreign-funded companies, which will raise the profitability of the TCM industry. (Click here for more - Chinese Language)

Latest Headlines
See All
UsernamePublicRestriction

Register

SC067729

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel